{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:53:41Z","timestamp":1768258421249,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03092-4","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T04:51:05Z","timestamp":1743655865000},"page":"538-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition"],"prefix":"10.1007","volume":"58","author":[{"given":"Andres","family":"Cordova Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold L.","family":"Dauerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanush","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"3092_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaccao.2019.11.001","volume":"1","author":"Y Ueki","year":"2019","unstructured":"Ueki Y, Vogeli B, Karagiannis A et al (2019) Ischemia and bleeding in cancer patients undergoing percutaneous coronary intervention. JACC CardioOncol 1:145\u2013155","journal-title":"JACC CardioOncol"},{"key":"3092_CR2","doi-asserted-by":"publisher","first-page":"590016","DOI":"10.3389\/fcvm.2021.590016","volume":"8","author":"I Costa","year":"2021","unstructured":"Costa I, Andrade FTA, Carter D et al (2021) Challenges and management of acute coronary syndrome in cancer patients. Front Cardiovasc Med 8:590016","journal-title":"Front Cardiovasc Med"},{"key":"3092_CR3","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J 40:2632\u20132653","journal-title":"Eur Heart J"},{"key":"3092_CR4","doi-asserted-by":"publisher","first-page":"e013000","DOI":"10.1161\/CIRCINTERVENTIONS.122.013000","volume":"17","author":"CM Campos","year":"2024","unstructured":"Campos CM, Mehran R, Capodanno D et al (2024) Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled High-Bleeding risk trials. Circ Cardiovasc Interv 17:e013000","journal-title":"Circ Cardiovasc Interv"},{"key":"3092_CR5","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","volume":"41","author":"A Bharadwaj","year":"2020","unstructured":"Bharadwaj A, Potts J, Mohamed MO et al (2020) Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 41:2183\u20132193","journal-title":"Eur Heart J"},{"key":"3092_CR6","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","volume":"23","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, Lopez-Fernandez T, Couch LS et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J Cardiovasc Imaging 23:e333\u2013e465","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3092_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","volume":"79","author":"M Writing Committee","year":"2022","unstructured":"Writing Committee M, Lawton JS, Tamis-Holland JE et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:197\u2013215","journal-title":"J Am Coll Cardiol"},{"key":"3092_CR8","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44:3720\u20133826","journal-title":"Eur Heart J"},{"key":"3092_CR9","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M et al (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 27:S0735-1097"},{"key":"3092_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2019.09.016","volume":"300","author":"RA Quintana","year":"2020","unstructured":"Quintana RA, Monlezun DJ, Davogustto G et al (2020) Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol 300:106\u2013112","journal-title":"Int J Cardiol"},{"key":"3092_CR11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","volume":"40","author":"JE Potts","year":"2019","unstructured":"Potts JE, Iliescu CA, Lopez Mattei JC et al (2019) Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the united States. Eur Heart J 40:1790\u20131800","journal-title":"Eur Heart J"},{"key":"3092_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation 140:240\u2013261","journal-title":"Circulation"},{"key":"3092_CR13","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ et al (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109:3122\u20133131","journal-title":"Circulation"},{"key":"3092_CR14","doi-asserted-by":"publisher","first-page":"620857","DOI":"10.3389\/fcvm.2021.620857","volume":"8","author":"DJ Monlezun","year":"2021","unstructured":"Monlezun DJ, Lawless S, Palaskas N et al (2021) Machine Learning-Augmented propensity score analysis of percutaneous coronary intervention in over 30 million cancer and Non-cancer patients. Front Cardiovasc Med 8:620857","journal-title":"Front Cardiovasc Med"},{"key":"3092_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/2048872617706501","volume":"7","author":"M Iannaccone","year":"2018","unstructured":"Iannaccone M, D\u2019Ascenzo F, Vadala P et al (2018) Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a bleemacs substudy. Eur Heart J Acute Cardiovasc Care 7:631\u2013638","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"3092_CR16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jacc.2024.08.051","volume":"84","author":"DJ Schneider","year":"2024","unstructured":"Schneider DJ, McMahon SR, Angiolillo DJ et al (2024) Platelet FcgammaRIIa as a marker of cardiovascular risk after myocardial infarction. J Am Coll Cardiol 84:1721\u20131729","journal-title":"J Am Coll Cardiol"},{"key":"3092_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.repc.2023.04.013","volume":"43","author":"M Nobre Menezes","year":"2024","unstructured":"Nobre Menezes M, Tavares da Silva M, Magalhaes A et al (2024) Interventional cardiology in cancer patients: A position paper from the Portuguese cardiovascular intervention association and the Portuguese Cardio-Oncology study group of the Portuguese society of cardiology. Rev Port Cardiol 43:35\u201348","journal-title":"Rev Port Cardiol"},{"key":"3092_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaccao.2020.04.009","volume":"2","author":"JR Wright","year":"2020","unstructured":"Wright JR, Chauhan M, Shah C et al (2020) The TICONC (Ticagrelor-Oncology) study: implications of P2Y(12) Inhibition for metastasis and Cancer-Associated thrombosis. JACC CardioOncol 2:236\u2013250","journal-title":"JACC CardioOncol"},{"key":"3092_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ehjcvp\/pvad041","volume":"9","author":"J Tjerkaski","year":"2023","unstructured":"Tjerkaski J, Jernberg T, Alfredsson J et al (2023) Comparison between Ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. Eur Heart J Cardiovasc Pharmacother 9:627\u2013635","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03092-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03092-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03092-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:11:46Z","timestamp":1746065506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03092-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3092"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03092-4","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"23 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}